NLRP3 and Parkinson disease: In animal models of Parkinson’s disease [21], depression [15], inflammatory pain [22], and mechanisms, such as ubiquitination, autophagy, and mitophagy, inhibit NLRP3-mediated inflammasome activation, thereby reducing neuroinflammation and oxidative reactions and preserving neuronal activity.